All 2025 pre-filled syringe doses for the Canadian market to be made in Canada, marking a domestic production milestone CAMBRIDGE, MA – Moderna, Inc. (NASDAQ:MRNA) announced that Health Canada has… Read More
DLBCL is an aggressive cancer with a high risk of progression meaning urgent and effective treatments are needed for people who relapse or have refractory disease This Columvi regimen offers… Read More
Eligible Canadian patients with heterozygous familial hypercholesterolemia (HeFH) are one step closer to publicly funded access to cholesterol lowering treatment. MONTRÉAL, QC – Novartis Pharmaceuticals Canada Inc. is pleased to… Read More
Demonstrated significant hearing restoration in blast-induced sensorineural hearing loss models Promoted significant functional recovery and axonal regeneration in peripheral nerve injury models Reinforced NVG-291’s broad therapeutic potential with new data… Read More
LAVAL, QC – Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, announced that PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide) gel 1.2%… Read More
